Board Cancels Claims Of Patent Covering Treatment For Lymphomas
ALEXANDRIA, Va. — In a final written decision issued Oct. 4, the Patent Trial and Appeal Board agreed with an inter partes review (IPR) petitioner that six claims of a patented...To view the full article, register now.
Already a subscriber? Click here to view full article